How are we doing at providing the best stroke care for patients having a Stroke?
The Thrombectomy Capable Stroke Center at St. Vincent’s Medical Center monitors rates for timely and effective stroke care, comparing them against other hospitals in Connecticut. Note: Higher percentages are better.
| Performance Measures |
St. Vincent's
|
State Average |
| Percent of patients with an ischemic or hemorrhagic stroke who receive VTE (blood clots in the veins) prophylaxis on the day of admission or the following day. |
99.4%
|
96.4%
|
| Percent of patients with an ischemic stroke or TIA with a history of smoking who are, or whose caregivers are, given smoking cessation advice or counseling during the hospital stay. |
100%
|
98.8%
|
| Percent of ischemic stroke patients who arrive at the hospital within 210 minutes (3.5 hours) of last known well and for whom IV thrombolytic was initiated at this hospital within 270 minutes (4.5 hours). |
91.3%
|
94.2%
|
| Percent of patients with an ischemic stroke or TIA who are prescribed high-intensity statin therapy at discharge, or if under 75 years of age, are prescribed at least moderate-intensity statin therapy at discharge. |
97%
|
95.9%
|
| Percent of patients with an ischemic stroke or TIA who receive antithrombotic therapy by the end of hospital day 2. |
97.2%
|
96.6%
|
| Percent of patients with an ischemic stroke or TIA who receive antithrombotic therapy at discharge. |
100%
|
98.4%
|
| Percent of patients with an ischemic stroke or TIA with atrial fibrillation/flutter discharged on anticoagulation therapy. |
96.4%
|
98.6%
|
Additional publicly reported data can be found on the American Heart Association public reporting website.
St. Vincent’s Stroke Program monitors complications related to interventions for patients with acute ischemic stroke. For the stroke patients at St. Vincent’s Medical Center treated with IV the clot-dissolver Tenecteplase (TNK). Between January 1 and December 31, 2024, our complication rate from receiving IV TNK was 0%.
The program monitors the rate of complications after carotid endarterectomies (CEA) and carotid arterial stenting (CAS). These procedures both treat carotid artery stenosis by removing plaque, while the CAS can be used to widen the carotid artery.
The preferred goal of complication after CEA and CAS is to have a complication rate of less than 6% in symptomatic patients (patients who have had a recent TIA or stroke) and less than 3% in asymptomatic patients (patients who have not had a recent TIA or stroke). Between January 1 and December 31, 2024, our combined CEA and CAS complication rate was only 1.79%.